Geoffrey D Wool
Overview
Explore the profile of Geoffrey D Wool including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao K, Saucedo E, Basterreachea K, Yang S, Haworth K, Holland C, et al.
J Vasc Interv Radiol
. 2025 Jan;
PMID: 39890017
Purpose: The hypothesis of this study was that histotripsy, an ultrasound therapy that disrupts tissue mechanically through the action of bubble clouds, increases the short-term rate of acute thrombus clearance...
2.
McCartin M, Wool G, Thomas S, Panfil M, Schoenfeld D, Blumen I, et al.
Air Med J
. 2024 Jun;
43(4):348-356.
PMID: 38897700
Recent years have seen increased discussion surrounding the benefits of damage control resuscitation, prehospital transfusion (PHT) of blood products, and the use of whole blood over component therapy. Concurrent shortages...
3.
Mehr N, Storozuk T, Mikrut K, Wool G
Am J Clin Pathol
. 2024 May;
162(4):379-391.
PMID: 38741421
Objectives: To evaluate the utility of the dilute prothrombin time (DPT) in diagnosing antiphospholipid syndrome (APS), alone and when paired with the dilute Russell viper venom time (DRVVT). Methods: Dilute...
4.
5.
Crane G, Geyer J, Thakral B, Wang S, Wool G, Li K, et al.
Am J Clin Pathol
. 2024 Apr;
162(3):233-242.
PMID: 38597584
Objectives: Myeloproliferative neoplasm, unclassifiable (MPN-U, revised to MPN, not otherwise specified in the fifth edition of the World Health Organization classification) is a heterogeneous category of primary marrow disorders with...
6.
Rossouw T, Pretorius E, Wool G
Front Immunol
. 2023 Oct;
14:1285355.
PMID: 37818358
No abstract available.
7.
Wool G, Carll T
Int J Lab Hematol
. 2023 Aug;
45(5):643-658.
PMID: 37559473
United States Food and Drug Administration (FDA)-approved viscoelastic testing (VET) methodologies have significantly changed in the last 10 years, with the availability of cartridge-based VET. Some of these cartridge-based methodologies...
8.
Fuja C, Carll T, Mikrut K, Wool G
Am J Clin Pathol
. 2023 Jul;
160(5):455-465.
PMID: 37415401
Objectives: The sensitivity and specificity of clot lysis at 30 minutes after maximum clot strength (LY30), as measured by thromboelastography (TEG), for clinically significant hyperfibrinolysis have not been compared across...
9.
Sarkar A, Khandelwal S, Koma G, Kim H, Gruel Y, Rollin J, et al.
Blood Adv
. 2023 May;
7(15):4112-4123.
PMID: 37196641
Heparin-induced thrombocytopenia (HIT) is characterized by thrombocytopenia associated with a highly prothrombotic state due to the development of pathogenic antibodies that recognize human platelet factor 4 (hPF4) complexed with various...
10.
Roloff G, Wen F, Ramsland A, Artz A, Kosuri S, Stock W, et al.
Haematologica
. 2023 Jan;
108(8):2234-2239.
PMID: 36655425
No abstract available.